BISU news [b]Former Nestle Beverage Innovator [/b]and Product Lines Developer -- Named Chief Scientist at Bio-Solutions Corp
SAN ANTONIO, TX, Jun 05, 2012 (MARKETWIRE via COMTEX) -- Bio-Solutions Corporation (pinksheets:BISU), a leading manufacturer of healthy lifestyle nutraceuticals, announced today that Dr. Chandrasekhar Mallangi will play a leading role in product development. This announcement comes at the advent of Bio-Solutions' launch of Type2 Defense(TM), a state-of-the-art functional beverage for the management of Type 2 diabetes.*
Dr. Mallangi -- the former principal product developer for food giant Nestle SA -- has been named Bio-Solutions' chief scientist. Mallangi comes to Bio-Solutions with unmatched expertise in product formulation and widespread esteem in the natural foods industry. His extensive experience complements Bio-Solutions' innovative healthy lifestyle products. Mallangi will be overseeing development and quality control as Bio-Solutions continues to formulate cutting-edge nutraceuticals.
Dr. Mallangi holds a Ph.D. in Food Science and Technology from Oregon State University and is a member of the prestigious Institute of Food Technologists. He is distinguished by over 35 years of experience in the development of dairy-based drinks, fruit and vegetable juices and a variety of innovative healthy-lifestyle products. For the past 25 years Mallangi managed the nutrition product development team at Nestle SA producing health care nutritional supplements and functional beverage lines including Carnation Instant Breakfast(TM) and the original Nestle Sweet Success(TM). The Bio-Solutions team welcomes Dr. Chandrasekhar Mallangi, enthusiastically hailing his past accomplishments while looking forward to what they anticipate to be an exciting collaboration in years to come.
"We are proud that one of the industry's top professionals has agreed to join with Bio-Solutions Corp in such a critical role, developing and enhancing our exciting line of products," said Bill Gallagher, Financial Vice President of Bio Solutions, Inc. "He shares our goal of providing unique dietary supplements to assisting diabetics and pre diabetics in the support of healthy blood glucose levels to this rapidly growing market."
Bio-Solutions acquired Type2 Defense(TM) brand in September of 2012, including all formulas, copyrights, trademarks, records and research. The company has launched the new product to tap into the rapidly growing demand for diabetic and functional supplementation.
Type2 Defense will soon be sold on the company's website www.type2defense.com (under development).
Type 2 diabetes -- one of the five most prevalent illnesses worldwide -- affects 100 million individuals in the United States alone. Now more than ever, this staggering and ever-growing population is seeking to reclaim control of their wellbeing through natural holistic supplementation. Compared to other consumer groups, diabetics are 1.6 times more likely to use alternative medicine either exclusively or as a complement to traditional treatment.(1) According to Clinical Diabetes,
As the incidence of diabetes increases to epidemic proportions, people with diabetes are turning more and more to alternative therapies to help manage this condition, despite the availability of numerous traditional therapies. In fact, Americans spent almost $34 billion out of pocket on complementary and alternative products, practitioner visits, and materials in 2007, according to data from the National Health Interview Survey.(2)
The demand for natural products that effectively control glucose continues to rise. Even in times of general economic distress, consumers increase their consumption of natural health products.(3) These savvy consumers know that effective organic products like Type2 Defense can improve everyday wellbeing and save money on future medical costs by maintaining health.
Clinical trials have shown that certain natural ingredients effectively normalize blood glucose levels in humans.(4) Type2 Defense contains proven ingredients like green and white tea, concentrated cinnamon, and chromium polynicotinate. In addition to choosing ingredients based on the best scientific results, Type2 Defense uses organic materials and offers its groundbreaking formula as a delicious blueberry beverage.* Type2 Defense is sold in packages containing 30 travel-friendly packets of easy-to-mix powder, making it easy for customers to have their daily dose at home or on the go.
Type2 Defense recognizes the enormity of demand for its product. Our forecast for success stems from the efficacy of the Type2 Defense system and our plans to get the word out through an extensive web-based publicity and consumer education campaign utilizing social media and celebrity sponsorship. We see this not only as an excellent business plan that promises to increase share values but also -- and perhaps more importantly -- as a means invest in further research and development in our battle against this devastating disease.
"Safe Harbor" Statement under the Private Securities Litigation Reform Act of 1995: This release includes forward-looking statements intended to qualify for the safe harbor from liability established by the Private Securities Litigation Reform Act of 1995. All statements which address actual results could differ materially from those expressed or implied in forward-looking statements. These statements are made on the basis of management's views and assumptions. As a result, there can be no assurance that management's expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as management "believes," "expects," "anticipates," "foresees," "forecasts," "estimates" or other words or phrases of similar import. Similarly, statements in this release that describe the Company's business strategy, outlook, objectives, plans, intentions or goals also are forward-looking statements. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. Management cautions that the ability to attract clients and generate business may be affected by a decline in the Company's financial ratings, the competitive environment, the Company's ability to raise sufficient capital to meet the collateral requirements associated with its current business and to fund the Company's continuing operations and changes in market conditions.
* Product statements have not been evaluated by the FDA. The products are not intended to diagnose, treat, cure or prevent disease.
(1) Campbell, A. P. (2010). Diabetes and dietary supplements. Clinical Diabetes, 28(1), 35+. Retrieved from http://go.galegroup.com.queens.ezproxy.cuny.edu :2048/ps/i.do?id=GALE%7CA219009220&v=2.1&u=cuny_queens&it=r&p=HRCA&sw=w
(2) Campbell, A. P. (2010). Diabetes and dietary supplements. Clinical Diabetes, 28(1), 35+. Retrieved from http://go.galegroup.com.queens.ezproxy.cuny.edu :2048/ps/i.do?id=GALE%7CA219009220&v=2.1&u=cuny_queens&it=r&p=HRCA&sw=w
(3) Johnston, J. (2009, September). Herbal Supplements Are Hot Sellers. Drug Topics, 153, 27+. Retrieved June 4, 2012, from Questia database: http://www.questia.com/PM.qst?a=o&d=5036598633
(4) Lee, T. & Dugoua, J. 2011. Nutritional Supplements and their Effects on Glucose. Current Diabetes Reports, 10(2), p. 210-214.
Contact
Bill Gallagher
jagcapital@yahoo.com
SOURCE: Bio-Solutions Corp
